NC
APYX icon

Northpointe Capital’s Apyx Medical APYX Stock Holding History

Northpointe Capital’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-150,000
Closed -$359K – 192
2015
Q1 		$359K Buy
+150,000
New +$499K 0.04% 228

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Northpointe Capital's APYX Position: Q2 2015 in Review

Northpointe Capital sold out of Apyx Medical (APYX) in Q2 2015, closing a stake of 150,000 shares — an estimated $359K sold.

Northpointe Capital first reported a position in APYX in Q1 2015 and held it in 1 quarter. The position peaked at $359K in Q1 2015. 32 funds tracked by Wall St. Rank hold APYX as of Q2 2015.

  • Northpointe Capital reported no remaining Apyx Medical position as of Q2 2015 after selling out during the quarter.
  • Northpointe Capital sold 150,000 Apyx Medical shares in Q2 2015, an estimated $359K.
  • Northpointe Capital first reported a position in Apyx Medical in Q1 2015 and held it in 1 quarter.
  • Northpointe Capital's Apyx Medical position peaked at $359K in Q1 2015.
  • 32 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2015.

Based on Northpointe Capital's 13F filing for Q2 2015, filed 30 Jul 2015.